Compare Hasbro, Inc. (HAS) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hasbro, Inc. vs Twist Bioscience Corp — how do they compare? Hasbro, Inc. trades at $88.58 (market cap $11.53B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Hasbro, Inc. is far larger — about 2.1× Twist Bioscience Corp's market cap, and Hasbro, Inc. pays a 3.44% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| HAS | TWST | |
|---|---|---|
Market Cap | $11.53B | $5.45B |
Sector | Consumer Cyclical | Health |
52-Week High | $105.88 | $102.88 |
52-Week Low | $70.95 | $24.16 |
Enterprise Value | $13.80B | $5.37B |
Dividend Yield | 3.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hasbro, Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
